Len Verbeke

2.5k total citations
23 papers, 1.2k citations indexed

About

Len Verbeke is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Len Verbeke has authored 23 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hepatology, 10 papers in Surgery and 10 papers in Epidemiology. Recurrent topics in Len Verbeke's work include Liver Disease and Transplantation (11 papers), Liver Disease Diagnosis and Treatment (10 papers) and Drug Transport and Resistance Mechanisms (6 papers). Len Verbeke is often cited by papers focused on Liver Disease and Transplantation (11 papers), Liver Disease Diagnosis and Treatment (10 papers) and Drug Transport and Resistance Mechanisms (6 papers). Len Verbeke collaborates with scholars based in Belgium, Germany and Spain. Len Verbeke's co-authors include Wim Laleman, Frederik Nevens, Ricard Farré, Jonel Trebicka, Petra Windmolders, Ingrid Vander Elst, Sabine Klein, Tania Roskams, Tim Vanuytsel and Mina Komuta and has published in prestigious journals such as PLoS ONE, Hepatology and Gut.

In The Last Decade

Len Verbeke

23 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Len Verbeke Belgium 13 645 557 427 314 174 23 1.2k
Yuichi Yamazaki Japan 17 460 0.7× 398 0.7× 296 0.7× 169 0.5× 233 1.3× 75 1.0k
Anne Davit–Spraul France 16 337 0.5× 281 0.5× 762 1.8× 718 2.3× 183 1.1× 26 1.4k
Ronald Oude Elferink Netherlands 19 270 0.4× 288 0.5× 359 0.8× 507 1.6× 212 1.2× 30 1.0k
Anna Baghdasaryan Austria 11 348 0.5× 325 0.6× 382 0.9× 393 1.3× 109 0.6× 18 771
Hubert Hayden Austria 15 465 0.7× 422 0.8× 167 0.4× 137 0.4× 233 1.3× 33 920
Kei Moriya Japan 16 478 0.7× 347 0.6× 203 0.5× 125 0.4× 364 2.1× 61 1.2k
Daniel Zamora‐Valdés Mexico 18 512 0.8× 321 0.6× 319 0.7× 112 0.4× 161 0.9× 37 978
Jaspreet S. Gujral United States 11 365 0.6× 511 0.9× 393 0.9× 285 0.9× 273 1.6× 12 1.2k
Seikan Hai Japan 18 328 0.5× 414 0.7× 492 1.2× 253 0.8× 115 0.7× 63 959
Frank Erhard Uschner Germany 21 821 1.3× 671 1.2× 281 0.7× 43 0.1× 206 1.2× 51 1.2k

Countries citing papers authored by Len Verbeke

Since Specialization
Citations

This map shows the geographic impact of Len Verbeke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Len Verbeke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Len Verbeke more than expected).

Fields of papers citing papers by Len Verbeke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Len Verbeke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Len Verbeke. The network helps show where Len Verbeke may publish in the future.

Co-authorship network of co-authors of Len Verbeke

This figure shows the co-authorship network connecting the top 25 collaborators of Len Verbeke. A scholar is included among the top collaborators of Len Verbeke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Len Verbeke. Len Verbeke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hees, Stijn Van, et al.. (2023). A first case of Chimaeribacter species catheter-related bloodstream infection. Acta Clinica Belgica. 78(6). 521–523. 1 indexed citations
2.
Gilbo, Nicholas, Ina Jochmans, Mauricio Sainz‐Barriga, et al.. (2019). Age Matching of Elderly Liver Grafts With Elderly Recipients Does Not Have a Synergistic Effect on Long-term Outcomes When Both Are Carefully Selected. Transplantation Direct. 5(4). e342–e342. 9 indexed citations
3.
Verbeke, Len, et al.. (2018). Therapeutic Intranodal Lymphangiography for Refractory Chylous Ascites Complicating Acute Necrotic Pancreatitis. Journal of Gastrointestinal and Liver Diseases. 27(2). 195–197. 6 indexed citations
4.
Ceulemans, Laurens J., Len Verbeke, Jean-Paul Decuypere, et al.. (2017). Farnesoid X Receptor Activation Attenuates Intestinal Ischemia Reperfusion Injury in Rats. PLoS ONE. 12(1). e0169331–e0169331. 50 indexed citations
5.
Ceulemans, Laurens J., Gert De Hertogh, Ricard Farré, et al.. (2017). Villin-1 Is a Novel Serological Biomarker for Intestinal Ischemia and Reperfusion Injury in Rats and Humans. Transplantation. 101(6S2). S91–S91. 1 indexed citations
6.
Laleman, Wim, Van der Merwe, Len Verbeke, et al.. (2017). A new intraductal radiofrequency ablation device for inoperable biliopancreatic tumors complicated by obstructive jaundice: the IGNITE-1 study. Endoscopy. 49(10). 977–982. 38 indexed citations
7.
Deprez, Pierre H., Rodrigo Garcés-Durán, Tom G. Moreels, et al.. (2017). The economic impact of using single-operator cholangioscopy for the treatment of difficult bile duct stones and diagnosis of indeterminate bile duct strictures. Endoscopy. 50(2). 109–118. 64 indexed citations
8.
Ceulemans, Laurens J., et al.. (2016). The expanding role of the bile acid receptor farnesoid X in the intestine and its potential clinical implications. Acta chirurgica Belgica. 116(3). 156–163. 4 indexed citations
9.
Verbeke, Len, Inge Mannaerts, Robert Schierwagen, et al.. (2016). FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis. Scientific Reports. 6(1). 33453–33453. 183 indexed citations
10.
Verbeke, Len, Inge Mannaerts, Robert Schierwagen, et al.. (2016). In Toxic Cirrhotic Rats, the FXR Agonist Obeticholic Acid Reduces Liver Fibrosis Indirectly via an Anti-Inflammatory Effect in Liver Sinusoidal Endothelial Cells and Kupffer Cells. Journal of Hepatology. 64(2). S141–S141. 1 indexed citations
11.
Klein, Sabine, Jennifer Lehmann, Robert Schierwagen, et al.. (2015). Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis. Gut. 66(1). 145–155. 55 indexed citations
12.
Verbeke, Len, Ricard Farré, Bert Verbinnen, et al.. (2015). The FXR Agonist Obeticholic Acid Prevents Gut Barrier Dysfunction and Bacterial Translocation in Cholestatic Rats. American Journal Of Pathology. 185(2). 409–419. 170 indexed citations
13.
Kerbert, Annarein, Len Verbeke, Wim Laleman, et al.. (2015). Copeptin as an Indicator of Hemodynamic Derangement and Prognosis in Liver Cirrhosis. PLoS ONE. 10(9). e0138264–e0138264. 14 indexed citations
14.
Verbeke, Len, Inge Mannaerts, Robert Schierwagen, et al.. (2015). P0445 : Obeticholic acid, an FXR agonist, reduces hepatic fibrosis in a rat model of toxic cirrhosis. Journal of Hepatology. 62. S479–S479. 1 indexed citations
15.
Verbeke, Len, Ricard Farré, Jonel Trebicka, et al.. (2013). Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats. Hepatology. 59(6). 2286–2298. 213 indexed citations
16.
Francque, Sven, Wim Laleman, Len Verbeke, et al.. (2012). Increased intrahepatic resistance in severe steatosis: endothelial dysfunction, vasoconstrictor overproduction and altered microvascular architecture. Laboratory Investigation. 92(10). 1428–1439. 102 indexed citations
17.
Verbeke, Len, Frederik Nevens, & Wim Laleman. (2011). Bench-to-beside review: Acute-on-chronic liver failure - linking the gut, liver and systemic circulation. Critical Care. 15(5). 233–233. 40 indexed citations
18.
Laleman, Wim, Len Verbeke, Philippe Meersseman, et al.. (2011). Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions. Expert Review of Gastroenterology & Hepatology. 5(4). 523–537. 70 indexed citations
19.
Verbeke, Len, Michel Delforge, & Daan Dierickx. (2009). Current insight into thrombotic thrombocytopenic purpura. Blood Coagulation & Fibrinolysis. 21(1). 3–10. 15 indexed citations
20.
Cocquyt, V., Simon Van Belle, Robert Reinhardt, et al.. (2001). Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis. European Journal of Cancer. 37(7). 835–842. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuichi Yamazaki Breakdown of academic impact, for papers by Anne Davit–Spraul Breakdown of academic impact, for papers by Ronald Oude Elferink Breakdown of academic impact, for papers by Anna Baghdasaryan Breakdown of academic impact, for papers by Hubert Hayden Breakdown of academic impact, for papers by Kei Moriya Breakdown of academic impact, for papers by Daniel Zamora‐Valdés Breakdown of academic impact, for papers by Jaspreet S. Gujral Breakdown of academic impact, for papers by Seikan Hai Breakdown of academic impact, for papers by Frank Erhard Uschner
Rankless by CCL
2026